← Back to Search

Patients diagnosed with Lung cancer for Lung Cancer

Phase < 1
Waitlist Available
Led By Kolby Sidhu, MD
Research Sponsored by Hal C Charles
Eligibility Criteria Checklist
Specific guidelines that determine who can or cannot participate in a clinical trial
Must have
Be older than 18 years old
Timeline
Screening 3 weeks
Treatment Varies
Follow Up 4 months
Awards & highlights

Study Summary

The goal of this study is to determine the feasibility and efficiency of incorporating 19F MR functional lung imaging into the routine assessment of lung cancer patients prior to thoracic radiotherapy.

Eligible Conditions
  • Lung Cancer

Timeline

Screening ~ 3 weeks
Treatment ~ Varies
Follow Up ~4 months
This trial's timeline: 3 weeks for screening, Varies for treatment, and 4 months for reporting.

Treatment Details

Study Objectives

Outcome measures can provide a clearer picture of what you can expect from a treatment.
Primary outcome measures
Number of study patients consented (maximum 8)in order to result in 5 patients successfully completing both 19F functional MR imaging data sets
Proportion of study patients that successfully return for a re-assessment 19F MRI scan after completing radiotherapy.

Trial Design

1Treatment groups
Experimental Treatment
Group I: Patients diagnosed with Lung cancerExperimental Treatment1 Intervention
patients diagnosed with Lung cancer and Thoracic radiotherapy
Treatment
First Studied
Drug Approval Stage
How many patients have taken this drug
Perfluorinated Gas/Oxygen Mixture
2018
Completed Phase 2
~180

Find a Location

Who is running the clinical trial?

Hal C CharlesLead Sponsor
7 Previous Clinical Trials
277 Total Patients Enrolled
Kolby Sidhu, MDPrincipal InvestigatorDuke University Medical Center, Department of Radiation Oncology

Frequently Asked Questions

These questions and answers are submitted by anonymous patients, and have not been verified by our internal team.
Recent research and studies
clinicaltrials.govStudy
19F Thoracic Radiotherapy for Lung Cancer
Hal C Charles 2018. "19F Thoracic Radiotherapy for Lung Cancer". ClinicalTrials.gov. https://clinicaltrials.gov/ct2/show/NCT03315065.
~1 spots leftby May 2025
Unbiased ResultsWe believe in providing patients with all the options.
Your Data Stays Your DataWe only share your information with the clinical trials you're trying to access.
Verified Trials OnlyAll of our trials are run by licensed doctors, researchers, and healthcare companies.
Back to top